US Stock MarketDetailed Quotes

ACOR Acorda Therapeutics

Watchlist
  • 13.2110
  • +1.3010+10.92%
Close Mar 28 16:00 ET
  • 13.9800
  • +0.7690+5.82%
Post 16:41 ET
16.41MMarket Cap5.06P/E (TTM)

Acorda Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
-17.30%27.72M
-4.43%29.68M
-1.22%22.26M
-8.14%118.57M
-14.87%31.47M
6.53%33.51M
-2.31%31.05M
-21.93%22.53M
-15.62%129.07M
-3.13%36.97M
Operating revenue
-17.30%27.72M
-4.43%29.68M
-1.22%22.26M
-8.14%118.57M
-14.87%31.47M
6.53%33.51M
-2.31%31.05M
-21.93%22.53M
-15.62%129.07M
-3.13%36.97M
Cost of revenue
-69.22%3.39M
-65.17%3.07M
-45.80%3.23M
-25.63%30.33M
8.62%4.56M
-17.27%11.01M
-22.29%8.8M
-50.11%5.97M
21.71%40.79M
-61.28%4.2M
Gross profit
8.10%24.33M
19.59%26.61M
14.83%19.02M
-0.06%88.23M
-17.88%26.91M
23.98%22.51M
8.75%22.25M
-1.98%16.57M
-26.09%88.28M
19.96%32.77M
Operating expense
-0.07%32.05M
-20.92%31.07M
-13.03%31.59M
-21.33%130.27M
-39.75%22.59M
-18.28%32.07M
-7.42%39.28M
-21.73%36.32M
-19.76%165.58M
-16.47%37.5M
Selling and administrative expenses
0.67%23.15M
-27.41%21.83M
-16.42%22.51M
-14.58%106.26M
-7.69%26.25M
-22.37%23M
-7.11%30.07M
-20.70%26.94M
-18.47%124.4M
-13.49%28.44M
Research and development costs
-12.73%1.21M
1.64%1.55M
-18.18%1.39M
-44.30%5.8M
-12.01%1.2M
-28.38%1.38M
-35.76%1.53M
-64.33%1.69M
-54.72%10.42M
-68.40%1.37M
Depreciation amortization depletion
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%30.76M
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%30.76M
0.01%7.69M
-Depreciation and amortization
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%30.76M
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%7.69M
0.00%30.76M
0.01%7.69M
Other operating expenses
----
----
----
---12.55M
----
----
----
----
----
----
Operating profit
19.27%-7.72M
73.84%-4.46M
36.39%-12.57M
45.62%-42.04M
191.31%4.32M
54.65%-9.57M
22.48%-17.03M
33.05%-19.76M
11.05%-77.3M
73.09%-4.73M
Net non-operating interest income expense
-5.09%-7.83M
-3.50%-7.72M
1.10%-7.48M
5.79%-28.29M
20.57%-5.83M
-3.94%-7.45M
3.25%-7.45M
3.34%-7.56M
-0.91%-30.03M
5.39%-7.34M
Non-operating interest income
823.53%157K
190.00%58K
9,200.00%93K
38,080.00%1.91M
187,000.00%1.87M
1,600.00%17K
1,900.00%20K
-66.67%1K
-99.39%5K
-88.89%1K
Non-operating interest expense
6.45%7.64M
4.00%7.77M
0.12%7.57M
0.55%30.2M
16.29%8.53M
0.10%7.17M
-3.00%7.47M
-3.36%7.56M
-1.76%30.04M
-5.49%7.34M
Total other finance cost
19.24%347K
----
----
----
----
--291K
----
----
----
----
Other net income (expense)
22.54%5.61M
-81.11%825K
-61.25%1.18M
2,110.32%35.08M
437.80%23.09M
338.53%4.58M
-30.47%4.37M
320.52%3.05M
-119.41%-1.75M
88.77%-6.83M
Gain on sale of security
28,900.00%288K
-114.29%-1K
----
-97.49%29K
-102.40%-7K
-100.35%-1K
-99.13%7K
113.27%30K
-97.11%1.16M
182.72%292K
Special income (charges)
13.70%5.2M
-73.50%824K
-63.91%1.09M
1,267.56%33.8M
424.37%23.09M
307.53%4.58M
-43.23%3.11M
217.88%3.02M
90.70%-2.9M
88.26%-7.12M
-Less:Restructuring and merger&acquisition
-13.70%-5.2M
73.50%-824K
63.91%-1.09M
-330.02%-6.66M
-43.11%4.05M
-307.53%-4.58M
43.23%-3.11M
-217.88%-3.02M
109.37%2.9M
177.44%7.12M
-Less:Other special charges
----
----
----
---27.14M
----
----
----
----
----
----
Other non- operating income (expenses)
--115K
-99.84%2K
--92K
20,933.33%1.25M
--0
----
--1.25M
----
-103.59%-6K
-103.83%-7K
Income before tax
20.06%-9.94M
43.61%-11.35M
22.26%-18.86M
67.69%-35.25M
214.15%21.57M
58.78%-12.44M
14.00%-20.12M
33.71%-24.26M
-1.31%-109.07M
78.06%-18.9M
Income tax
-174.51%-1.06M
-107.40%-1.97M
-889.92%-2.04M
699.00%30.67M
45.80%2.43M
145.60%1.42M
5,102.45%26.56M
108.19%258K
36.58%-5.12M
153.62%1.67M
Net income
35.85%-8.89M
79.90%-9.38M
31.39%-16.82M
36.59%-65.92M
193.07%19.14M
48.82%-13.85M
-104.17%-46.68M
26.69%-24.52M
-4.38%-103.95M
75.23%-20.57M
Net income continuous Operations
35.85%-8.89M
79.90%-9.38M
31.39%-16.82M
36.59%-65.92M
193.07%19.14M
48.82%-13.85M
-104.17%-46.68M
26.69%-24.52M
-4.38%-103.95M
75.23%-20.57M
Minority interest income
Net income attributable to the parent company
35.85%-8.89M
79.90%-9.38M
31.39%-16.82M
36.59%-65.92M
193.07%19.14M
48.82%-13.85M
-104.17%-46.68M
26.69%-24.52M
-4.38%-103.95M
75.23%-20.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.85%-8.89M
79.90%-9.38M
31.39%-16.82M
36.59%-65.92M
193.07%19.14M
48.82%-13.85M
-104.17%-46.68M
26.69%-24.52M
-4.38%-103.95M
75.23%-20.57M
Basic earnings per share
35.90%-7.16
86.02%-7.55
62.70%-13.8
65.88%-66.8
145.66%15.8
77.02%-11.17
-17.93%-54.01
47.59%-37
20.54%-195.8
82.38%-34.6
Diluted earnings per share
35.90%-7.16
86.02%-7.55
62.70%-13.8
65.88%-66.8
132.95%11.4
77.02%-11.17
-17.93%-54.01
47.59%-37
20.54%-195.8
82.38%-34.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue -17.30%27.72M-4.43%29.68M-1.22%22.26M-8.14%118.57M-14.87%31.47M6.53%33.51M-2.31%31.05M-21.93%22.53M-15.62%129.07M-3.13%36.97M
Operating revenue -17.30%27.72M-4.43%29.68M-1.22%22.26M-8.14%118.57M-14.87%31.47M6.53%33.51M-2.31%31.05M-21.93%22.53M-15.62%129.07M-3.13%36.97M
Cost of revenue -69.22%3.39M-65.17%3.07M-45.80%3.23M-25.63%30.33M8.62%4.56M-17.27%11.01M-22.29%8.8M-50.11%5.97M21.71%40.79M-61.28%4.2M
Gross profit 8.10%24.33M19.59%26.61M14.83%19.02M-0.06%88.23M-17.88%26.91M23.98%22.51M8.75%22.25M-1.98%16.57M-26.09%88.28M19.96%32.77M
Operating expense -0.07%32.05M-20.92%31.07M-13.03%31.59M-21.33%130.27M-39.75%22.59M-18.28%32.07M-7.42%39.28M-21.73%36.32M-19.76%165.58M-16.47%37.5M
Selling and administrative expenses 0.67%23.15M-27.41%21.83M-16.42%22.51M-14.58%106.26M-7.69%26.25M-22.37%23M-7.11%30.07M-20.70%26.94M-18.47%124.4M-13.49%28.44M
Research and development costs -12.73%1.21M1.64%1.55M-18.18%1.39M-44.30%5.8M-12.01%1.2M-28.38%1.38M-35.76%1.53M-64.33%1.69M-54.72%10.42M-68.40%1.37M
Depreciation amortization depletion 0.00%7.69M0.00%7.69M0.00%7.69M0.00%30.76M0.00%7.69M0.00%7.69M0.00%7.69M0.00%7.69M0.00%30.76M0.01%7.69M
-Depreciation and amortization 0.00%7.69M0.00%7.69M0.00%7.69M0.00%30.76M0.00%7.69M0.00%7.69M0.00%7.69M0.00%7.69M0.00%30.76M0.01%7.69M
Other operating expenses ---------------12.55M------------------------
Operating profit 19.27%-7.72M73.84%-4.46M36.39%-12.57M45.62%-42.04M191.31%4.32M54.65%-9.57M22.48%-17.03M33.05%-19.76M11.05%-77.3M73.09%-4.73M
Net non-operating interest income expense -5.09%-7.83M-3.50%-7.72M1.10%-7.48M5.79%-28.29M20.57%-5.83M-3.94%-7.45M3.25%-7.45M3.34%-7.56M-0.91%-30.03M5.39%-7.34M
Non-operating interest income 823.53%157K190.00%58K9,200.00%93K38,080.00%1.91M187,000.00%1.87M1,600.00%17K1,900.00%20K-66.67%1K-99.39%5K-88.89%1K
Non-operating interest expense 6.45%7.64M4.00%7.77M0.12%7.57M0.55%30.2M16.29%8.53M0.10%7.17M-3.00%7.47M-3.36%7.56M-1.76%30.04M-5.49%7.34M
Total other finance cost 19.24%347K------------------291K----------------
Other net income (expense) 22.54%5.61M-81.11%825K-61.25%1.18M2,110.32%35.08M437.80%23.09M338.53%4.58M-30.47%4.37M320.52%3.05M-119.41%-1.75M88.77%-6.83M
Gain on sale of security 28,900.00%288K-114.29%-1K-----97.49%29K-102.40%-7K-100.35%-1K-99.13%7K113.27%30K-97.11%1.16M182.72%292K
Special income (charges) 13.70%5.2M-73.50%824K-63.91%1.09M1,267.56%33.8M424.37%23.09M307.53%4.58M-43.23%3.11M217.88%3.02M90.70%-2.9M88.26%-7.12M
-Less:Restructuring and merger&acquisition -13.70%-5.2M73.50%-824K63.91%-1.09M-330.02%-6.66M-43.11%4.05M-307.53%-4.58M43.23%-3.11M-217.88%-3.02M109.37%2.9M177.44%7.12M
-Less:Other special charges ---------------27.14M------------------------
Other non- operating income (expenses) --115K-99.84%2K--92K20,933.33%1.25M--0------1.25M-----103.59%-6K-103.83%-7K
Income before tax 20.06%-9.94M43.61%-11.35M22.26%-18.86M67.69%-35.25M214.15%21.57M58.78%-12.44M14.00%-20.12M33.71%-24.26M-1.31%-109.07M78.06%-18.9M
Income tax -174.51%-1.06M-107.40%-1.97M-889.92%-2.04M699.00%30.67M45.80%2.43M145.60%1.42M5,102.45%26.56M108.19%258K36.58%-5.12M153.62%1.67M
Net income 35.85%-8.89M79.90%-9.38M31.39%-16.82M36.59%-65.92M193.07%19.14M48.82%-13.85M-104.17%-46.68M26.69%-24.52M-4.38%-103.95M75.23%-20.57M
Net income continuous Operations 35.85%-8.89M79.90%-9.38M31.39%-16.82M36.59%-65.92M193.07%19.14M48.82%-13.85M-104.17%-46.68M26.69%-24.52M-4.38%-103.95M75.23%-20.57M
Minority interest income
Net income attributable to the parent company 35.85%-8.89M79.90%-9.38M31.39%-16.82M36.59%-65.92M193.07%19.14M48.82%-13.85M-104.17%-46.68M26.69%-24.52M-4.38%-103.95M75.23%-20.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.85%-8.89M79.90%-9.38M31.39%-16.82M36.59%-65.92M193.07%19.14M48.82%-13.85M-104.17%-46.68M26.69%-24.52M-4.38%-103.95M75.23%-20.57M
Basic earnings per share 35.90%-7.1686.02%-7.5562.70%-13.865.88%-66.8145.66%15.877.02%-11.17-17.93%-54.0147.59%-3720.54%-195.882.38%-34.6
Diluted earnings per share 35.90%-7.1686.02%-7.5562.70%-13.865.88%-66.8132.95%11.477.02%-11.17-17.93%-54.0147.59%-3720.54%-195.882.38%-34.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg